{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-021629","form_type":"8-K","ticker":"SYRA","cik":"0001922335","company_name":"Syra Health Corp","filed_at":"2026-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.284053+00:00","generated_at":"2026-05-14T22:03:52.845921+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Syra Health posts first profitable quarter in Q1 2026; net income $241K, EPS $0.02, revenue up 22%","bullets":["Net income of $241,000 vs net loss of $(472,265) in Q1 2025; EPS $0.02 vs ($0.04).","Total revenue $2.3M (+22% YoY); population health solutions grew 46% to $1.8M.","Gross margin expanded to 42.7%, up 11 ppt from 31.7%.","Cash on hand $2.9M; no long-term debt as of March 31, 2026.","Adjusted EBITDA improved to $244,495 from $(462,239) in prior year."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-021629","json":"https://secwatch.observer/filing/0001493152-26-021629.json","markdown":"https://secwatch.observer/filing/0001493152-26-021629.md","text":"https://secwatch.observer/filing/0001493152-26-021629.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1922335/000149315226021629/0001493152-26-021629-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1922335/000149315226021629/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T22:03:52.845921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"36b4cddc0698af089b00cc4f25bc656313a65720","claim":"Syra Health Corp reported first quarter ended March 31, 2026 results: revenue $2.3 million, net income $240,979, EPS $0.02 per share.","evidence_excerpt":"period ● Q1 2026 EPS grew to $0.02 per share versus ($0.04) in Q1 2025 ● Gross Margin rose to 42.7%, up 11 percentage points year-over-year ● Total revenue increased to $2.3 million, up 22% when compared to the prior year period Carmel, Ind., May 7, 2026 / PRNewswire – Syra Health Corp. (OTCQB: SYRA) (“Syra Health” or the “Company”), an integrated healthcare","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315226021629/0001493152-26-021629-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"$2.3 million"},{"label":"Net income","value":"$240,979"},{"label":"EPS","value":"$0.02 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}